Jehovah’s Witnesses and Blood Transfusions: What Human Rights Law Says
Introduction
Jehovah’s Witnesses and blood transfusions present a fundamental question under human rights law: can a person refuse medical treatment even when that decision could result in death? For a competent adult, the answer is generally yes. Under the European Convention on Human Rights, personal autonomy and bodily integrity provide substantial protection against unwanted medical intervention. Religious freedom adds a further dimension when refusal arises from sincerely held beliefs. Different legal considerations apply to children, patients who lack decision-making capacity, and emergencies in which a patient's wishes cannot reliably be established.
On September 18, 2026, Jehovah’s Witnesses announced a major revision of their longstanding religious restrictions on blood transfusions. Members may now decide individually whether to accept red blood cells, white blood cells, plasma, and platelets obtained from donated blood. The prohibition on transfusions of whole blood remains unchanged. The announcement followed an earlier adjustment in March concerning the collection, storage, and transfusion of a patient's own blood.
The consequences of the former restrictions attracted renewed attention following a BBC News investigation published on November 7, 2026. It reported the death of Isaac Valdez, a 26-year-old Jehovah’s Witness in Texas who refused treatment involving blood transfusions after suffering a brain hemorrhage. Valdez died on August 26, just 23 days before the September revision. His family's account raises difficult questions about the consequences of religious medical decisions, although the available evidence does not establish that his death caused the policy change.
These circumstances bring three different forms of authority into focus. A religious organization may establish rules governing its members' conduct. Individuals possess legally protected interests in deciding what happens to their bodies. States and healthcare professionals have responsibilities to protect life and provide appropriate medical care. The interaction between these interests depends on the patient's circumstances and the law governing the proposed treatment.
1. Jehovah’s Witnesses and the 2026 Blood Policy Change
Jehovah’s Witnesses have historically regarded the medical use of blood as an issue of religious obedience. Their teaching rests on an interpretation of biblical instructions concerning blood, which the denomination has applied to certain medical procedures. For decades, this interpretation shaped decisions about surgery, emergency treatment, blood donations, and advance medical directives.
The practical consequences have depended partly on distinctions within transfusion medicine. Whole blood contains several principal components, but modern treatment frequently involves administering particular components rather than whole blood. The denomination developed different rules concerning these products, smaller blood fractions, and procedures involving a patient's own blood.
The 2026 revisions significantly altered those distinctions. Members gained greater discretion to accept treatments previously excluded under denominational guidance. The legal significance lies in the need to establish each patient's actual wishes rather than assume that religious affiliation determines which interventions will be accepted or refused.
1.1 The Religious Prohibition on Blood Transfusions
Jehovah’s Witnesses principally rely on Genesis 9:4, Leviticus 17:10–14, and Acts 15:28–29 in explaining their position concerning blood. The passages address the treatment or consumption of blood, and the denomination interprets the biblical instruction to abstain from blood as extending to transfusions. This interpretation is a matter of religious doctrine rather than a conclusion required by medical science or international law.
The modern prohibition developed in 1945. For much of the subsequent period, the denomination's guidance excluded transfusions of whole blood and its four principal components: red cells, white cells, plasma, and platelets. Other products, particularly certain fractions derived from blood components, eventually became matters of individual conscience. These distinctions were important because a product's medical purpose and composition could affect whether a member considered it religiously acceptable.
Jehovah’s Witnesses have also used advance medical documents to communicate their opposition to particular blood products. Commonly called "No Blood" cards, such documents can provide information when an individual becomes unconscious or otherwise unable to communicate. Their legal effect is determined by the patient's circumstances and the applicable law of medical consent. A religiously issued or inspired document does not acquire identical legal force in every jurisdiction.
The denomination generally supports conventional healthcare and does not reject medical intervention as a whole. Members may accept surgery, medication, diagnostic procedures, and other treatments consistent with their individual decisions. A person who refuses transfusion may simultaneously seek every available means of recovery that does not conflict with those wishes.
1.2 What Changed in March and September 2026?
On March 20, 2026, the Governing Body of Jehovah’s Witnesses announced a clarification concerning the use of a patient's own blood. Collection, storage, and subsequent transfusion of that blood became matters for individual conscience. Earlier guidance had generally excluded storing blood for later transfusion, although certain procedures involving the patient's blood had already been treated differently (Jehovah’s Witnesses, 2026a; AABB, 2026a).
The September 18 announcement extended personal discretion to the four principal components of donated blood. Members may now decide whether to receive red cells, white cells, plasma, or platelets from another person. They may also make individual decisions about donating blood specifically for use in producing components or fractions. The organization expressly maintained its prohibition on whole-blood transfusions (Jehovah’s Witnesses, 2026b; AABB, 2026b).
The distinction has considerable clinical significance. Red blood cell transfusions may be required to address severe anemia or substantial blood loss, while plasma and platelets serve different therapeutic purposes. The September revision allows a member to consider these interventions separately. It does not mean that all members will accept them, or that the religious position concerning whole blood has been abandoned.
Paul Gillies, the denomination's international spokesperson, explained the adjustment as an application of biblical principles to contemporary medical procedures. According to the organization's September statement, decisions about blood components are matters of personal conscience, and congregations are not to determine those choices for individual members. The explanation reflects the denomination's stated position; it does not establish why the leadership adopted the revision at that particular time.
The distinction between organizational permission and individual consent remains decisive. A patient may continue to refuse every blood component despite the revised guidance. Another may accept red cells but reject plasma or platelets. Religious permission does not itself authorize a physician to administer a treatment, just as a denominational restriction cannot substitute for an independent determination of the patient's legally effective wishes.
1.3 Isaac Valdez: A Death Before the September Revision
Isaac Valdez was a 26-year-old Jehovah’s Witness from Waxahachie, Texas. According to a BBC News investigation published on November 7, 2026, he experienced an epileptic seizure while visiting a local library in August. He reportedly struck his head during the seizure and suffered a brain hemorrhage, requiring urgent hospital treatment (BBC News, 2026).
The BBC reported that Valdez carried a "No Blood" card indicating his refusal of transfusions on religious grounds. According to the account, an initial procedure intended to drain fluid from his brain did not proceed because of concerns surrounding the use of blood. Valdez subsequently regained consciousness and was able to speak. During that period, he reportedly reaffirmed his opposition to transfusions.
His condition later deteriorated, and he entered a coma. The family's account, as reported by the BBC, described a neurosurgeon advising that an emergency operation involving blood transfusion offered a prospect of saving his life. The family chose to respect Valdez's previously expressed refusal. He died on August 26, 2026, after life support was withdrawn.
The September policy change occurred 23 days later. Valdez's twin brother, Jacob, who had left Jehovah’s Witnesses, publicly questioned why the religious leadership had not revised its position earlier. He believed that his brother might have survived had the new policy already existed. His criticism concerned both the timing of the announcement and the authority exercised through the denomination's former restrictions.
The medical account is based on reporting and family testimony rather than publicly available judicial findings or a complete independent examination of hospital records. It does not establish that the religious organization caused Valdez's death, that the proposed surgery would certainly have prevented it, or that Valdez would have accepted a relevant blood component under the revised guidance. No established causal connection has been demonstrated between his death and the Governing Body's subsequent decision.
The case nevertheless illustrates why the distinction between religious influence and personal autonomy requires careful examination. Valdez reportedly reaffirmed his refusal while conscious, an important circumstance when considering whether a medical decision represented his own wishes. His treatment occurred in Texas, where American law governs the relevant questions of consent and liability. European human rights jurisprudence cannot be applied to the incident as though it were binding on the hospital, but it offers a developed comparative framework for understanding the issues involved.
2. The Right to Refuse a Blood Transfusion
The legal protection of medical refusal arises from the recognition that individuals ordinarily possess authority over interventions affecting their bodies. A treatment may be beneficial, urgently recommended, or necessary to prevent death without automatically becoming lawful to administer against a competent adult's wishes.
Within the European human rights system, three Convention provisions are particularly relevant. Article 8 protects respect for private life, including bodily integrity and personal autonomy. Article 9 safeguards freedom of religion, while Article 2 requires states to protect life. These rights engage different interests and cannot be reduced to a general rule that religious freedom invariably prevails over medical necessity.
The broader foundations of human rights place dignity and individual freedom at the center of legal protection. In medical settings, their practical application requires attention to capacity, informed consent, the clarity of the patient's wishes, and the legal authority for any proposed intervention.
2.1 Article 8 ECHR and the Right to Medical Autonomy
Article 8 of the European Convention on Human Rights guarantees respect for private and family life. The European Court of Human Rights interprets private life as encompassing physical integrity and personal autonomy. Consequently, the administration of medical treatment without valid consent may interfere with Article 8 even when the intervention is intended to preserve health or save life.
Medical autonomy includes the ability to evaluate treatment according to personal convictions and priorities. A capable patient may understand that refusing blood could be fatal while concluding that accepting it would violate deeply held beliefs. That decision can remain legally effective despite disagreement from healthcare professionals.
Article 8 is not an absolute right. Article 8(2) permits interference where it is in accordance with law, pursues a legitimate objective, and is necessary in a democratic society. Protecting health or the rights of others may justify particular restrictions. The existence of a serious medical risk, however, does not eliminate the requirement to establish a lawful and proportionate basis for intervention.
In Jehovah’s Witnesses of Moscow and Others v. Russia (2010), the European Court explained that personal autonomy would lose much of its significance if individuals could make only those medical decisions considered prudent by others. The Court recognized that imposing treatment on a competent adult despite refusal interferes with bodily integrity, including where refusal could result in death.
This approach protects medical self-determination generally. Religious conviction can explain the importance of a particular refusal, but a patient does not have to belong to Jehovah’s Witnesses to enjoy the protection of bodily autonomy under Article 8.
2.2 Freedom of Religion and the Right to Life
Article 9 of the Convention protects freedom of thought, conscience, and religion. The freedom to hold or adopt religious beliefs enjoys particularly strong protection. Manifestations of religion may be subject to limitations prescribed by law and necessary for the purposes specified in Article 9(2), including the protection of health and the rights and freedoms of others.
For a Jehovah’s Witness, refusal of blood may constitute an expression of religious conviction as well as a decision concerning bodily integrity. The religious dimension reinforces the importance of establishing the patient's own wishes. It does not mean that every decision made by a member is necessarily free from pressure, nor that religious motivation removes the ordinary legal requirements governing consent.
Article 2 protects the right to life and imposes positive obligations on states. In healthcare, these obligations include maintaining appropriate legal and institutional safeguards. Yet the existence of a duty to protect life does not give public authorities unrestricted permission to impose medical interventions on competent adults who have made informed decisions to refuse them.
A patient who rejects transfusion does not necessarily intend to die. Such a person may seek urgent surgery, accept medication, request appropriate alternatives, and wish to survive. The European Court recognized this distinction in Pindo Mulla v. Spain (2024), where the applicant wanted treatment for her medical condition but opposed blood transfusions specifically.
The relationship between life and autonomy also appears in the wider development of international human rights protection. The Universal Declaration of Human Rights recognizes life and freedom of religion as fundamental interests. The precise legal consequences of a medical refusal, however, depend on the applicable binding instruments and domestic consent law.
2.3 International Standards on Consent and Religion
The International Covenant on Civil and Political Rights provides a broader treaty framework. Article 6 protects the right to life, Article 17 addresses unlawful or arbitrary interference with privacy, and Article 18 safeguards freedom of thought, conscience, and religion. Article 18(3) permits limitations on the manifestation of religion only under specified conditions, including necessity for the protection of public health or the fundamental rights and freedoms of others (ICCPR, 1966).
These provisions do not establish a single international system governing every advance medical directive, hospital emergency, or refusal of life-sustaining treatment. The Covenant binds its states parties, while domestic legislation and courts determine many of the procedures through which patient autonomy is exercised. The distinction between treaty obligations and their national implementation is fundamental to international human rights law.
The Council of Europe's Convention on Human Rights and Biomedicine, commonly known as the Oviedo Convention, addresses medical consent more directly. Article 5 establishes free and informed consent as the general rule for medical interventions. Article 6 provides safeguards for persons unable to consent, while Article 8 permits medically necessary intervention in qualifying emergencies when appropriate consent cannot be obtained.
Article 9 requires previously expressed wishes concerning medical interventions to be taken into account when a patient is unable to communicate. Its wording does not make every advance refusal unconditionally binding. The legal effect of such instructions depends partly on national arrangements. The Convention applies to its contracting parties and must not be treated as binding law throughout Europe or as a source of medical-consent obligations in the United States.
UNESCO's Universal Declaration on Bioethics and Human Rights, adopted in 2005, also emphasizes informed consent and protection for persons lacking capacity. It is a nonbinding declaration rather than a treaty. Its principles can inform ethical and legal analysis, but they do not independently determine whether a particular transfusion is lawful.
3. The European Court's Blood-Transfusion Jurisprudence
The European Court of Human Rights has considered Jehovah’s Witnesses' medical refusals in cases involving restrictions on religious organizations and unwanted treatment of individual patients. These judgments address related questions but arise in different procedural contexts.
The distinction is important. Proceedings against a religious organization require the Court to examine whether state interference with religious activities is justified. A complaint concerning an unwanted transfusion focuses more directly on the patient's autonomy and the safeguards governing medical decision-making.
The judgments also demonstrate the relationship between international human rights standards and domestic legal systems. National courts and medical authorities apply their own legislation while remaining responsible, where the Convention applies, for meeting Convention requirements. The relationship between international law and municipal law helps explain why a regional human rights judgment cannot automatically determine the result of every domestic medical dispute.
3.1 Jehovah’s Witnesses of Moscow and Taganrog
In Jehovah’s Witnesses of Moscow and Others v. Russia (2010), the European Court considered the dissolution of the Moscow religious community and the restrictions imposed on its activities. Russian authorities had relied on allegations concerning religious practices, including the encouragement of members to refuse medically recommended blood transfusions.
The Court examined these allegations in the context of freedom of religion and association. It rejected the assumption that the state's interest in protecting health automatically outweighed competent adults' rights to determine their medical treatment. The Court emphasized the importance of authentic personal choice and found that the authorities had not justified the restrictions imposed on the community.
The reasoning concerning medical autonomy appears particularly in paragraphs 134–142 of the judgment. The Court distinguished voluntary refusal from circumstances involving coercion or improper influence. A medical decision does not become legally invalid merely because it reflects religious beliefs or appears unwise to others (Jehovah’s Witnesses of Moscow and Others v. Russia, 2010).
The distinction was developed further in Taganrog LRO and Others v. Russia (2022). Among the allegations used to justify restrictions on Jehovah’s Witnesses was the death of a woman who had refused a blood transfusion. The Russian courts had attributed responsibility to the religious community because its teachings encouraged abstention from blood.
The European Court found no sufficient evidence that improper pressure had displaced the woman's independent wishes. In paragraphs 161–165, it reaffirmed the importance of medical self-determination and rejected attributing her death to the religious organization solely because she had followed its teaching. Religious persuasion and unlawful coercion are not legally interchangeable (Taganrog LRO and Others v. Russia, 2022).
Neither judgment establishes immunity where a religious organization or another person actually coerces a patient. Both concerned state restrictions on religious activities rather than judicial authorization for a particular hospital intervention. Their descriptions of Jehovah’s Witnesses' blood restrictions also reflect the historical policy existing when the relevant events occurred, rather than the revised guidance announced in September 2026.
3.2 Pindo Mulla v. Spain: Transfusion Without Consent
The Grand Chamber judgment in Pindo Mulla v. Spain (2024) addresses the administration of blood despite an individual patient's documented refusal. Rosa Edelmira Pindo Mulla, a Jehovah’s Witness living in Spain, had prepared an advance medical directive and a lasting power of attorney in 2017. Both recorded her refusal of blood transfusions even where her life was at risk. She remained willing to accept other appropriate medical treatment.
In 2018, Pindo Mulla was admitted to a hospital in Soria with serious internal bleeding. When transfusion was proposed, she signed a document confirming her refusal. She was subsequently transferred to a hospital in Madrid that could provide treatment without blood transfusions. Her medical condition nevertheless became critical, and the treating doctors sought urgent judicial authorization.
The information presented to the duty judge inadequately described the patient's actual position. It suggested that she had refused medical treatment generally, rather than blood transfusions specifically. The judge was not supplied with essential information concerning her written instructions and decision-making capacity. Authorization was granted for interventions considered necessary to preserve her life, and she subsequently received red blood cell transfusions during surgery.
On September 17, 2024, the Grand Chamber unanimously found a violation of Article 8 interpreted in light of Article 9. The Court did not establish a separate violation of Article 9. Its conclusion concerned deficiencies in the decision-making process that led to the authorization of treatment against the applicant's documented wishes (Pindo Mulla v. Spain, 2024, §§125–184).
The judgment establishes demanding safeguards for decisions involving refusal of life-saving treatment. An effective refusal must be made freely and autonomously by a person possessing the relevant capacity. It must also be clear, specific, unambiguous, and representative of the patient's current position. Where doubts arise, healthcare professionals must make every reasonable effort to determine the patient's wishes before proceeding.
The Court also recognized the legal difficulty of genuine emergencies. Where reasonable grounds for doubting a refusal remain despite appropriate efforts to resolve them, essential medical intervention may be compatible with the Convention. The duty to protect life becomes particularly relevant when the patient's authentic decision cannot be reliably established. A genuine emergency does not, however, provide an unrestricted justification for disregarding a clearly established refusal.
Advance directives require additional legal safeguards. The Grand Chamber recognized that European states retain a margin of appreciation regarding whether such directives have binding effect and the formal arrangements governing them. Where a state establishes a system through which patients can register instructions, that system must function effectively. Spain had adopted detailed legal protections, but their operation in Pindo Mulla's case failed to provide sufficient respect for her autonomy.
The judgment's significance extends beyond religious medical refusal. It establishes that an adult patient's wishes must remain central to the treatment decision, even where clinicians consider the intervention necessary to preserve life. The September 2026 revision of Jehovah’s Witnesses' teaching does not displace that principle or automatically alter the legal effect of instructions made before the announcement.
4. Capacity, Advance Directives, and Emergency Treatment
The legal protection of medical autonomy depends partly on the ability of the patient to make and communicate decisions. A competent adult who understands the consequences of refusing treatment occupies a different legal position from a person who lacks capacity or whose wishes cannot be reliably determined.
Advance medical decisions become important when patients anticipate circumstances in which they may be unable to communicate. Such documents can preserve individual autonomy, but their legal effect depends on validity, applicability, and the governing statutory framework. A statement of religious identity is not necessarily equivalent to a legally effective refusal of a particular intervention.
England and Wales provide a detailed example through the Mental Capacity Act 2005. Its provisions concerning capacity and advance decisions must be distinguished from the legal arrangements of other jurisdictions, including Scotland, Northern Ireland, and the United States.
4.1 Capacity, Informed Refusal, and Religious Influence
The Mental Capacity Act 2005 establishes that a person must be presumed to possess capacity unless lack of capacity is demonstrated. It also requires appropriate assistance with decision-making and states that an unwise decision does not, by itself, establish incapacity (Mental Capacity Act 2005, s. 1).
Capacity is decision-specific. Under sections 2 and 3, the assessment concerns whether an impairment or disturbance affecting the mind or brain prevents the person from understanding, retaining, using or weighing relevant information, or communicating a decision. A patient's religious identity cannot substitute for this assessment.
A Jehovah’s Witness may fully understand that refusing transfusion could result in death while maintaining a sincere objection to the procedure. A physician may strongly disagree with the decision and explain its consequences. Neither disagreement nor the seriousness of the potential outcome establishes that the patient lacks the capacity to decide.
Voluntariness requires a separate inquiry. Religious teachings may substantially influence personal choices without necessarily amounting to coercion. Evidence of threats, intimidation, deception, or other improper pressure may nonetheless raise concerns about whether the refusal represents the patient's authentic wishes.
Healthcare professionals should provide opportunities for patients to discuss treatment privately where appropriate. Relatives and hospital liaison representatives may assist with communication or identifying acceptable alternatives, but their involvement must not replace the decision of a competent patient. The legal inquiry concerns the individual's own capacity, understanding, and voluntary choice.
4.2 Advance Directives and Earlier Blood Refusals
Advance decisions permit adults to refuse specified treatments before losing decision-making capacity. Under sections 24–26 of the Mental Capacity Act 2005, a valid and applicable advance refusal has the same effect as a refusal made by a person with capacity at the time treatment is proposed.
Additional requirements apply to life-sustaining treatment. The refusal must be documented and signed in the legally prescribed manner, witnessed, and accompanied by an express statement that it applies even if life is at risk. The directive must also remain valid and applicable to the particular treatment and circumstances (Mental Capacity Act 2005, s. 25).
The Court of Protection addressed these requirements in Re PW (Jehovah’s Witness: Validity of Advance Decision) [2021] EWCOP 52. PW was an 80-year-old Jehovah’s Witness with Alzheimer's dementia and severe anemia arising from internal bleeding. She had signed an advance refusal of blood in 2001. The document satisfied the relevant formal requirements and applied to the treatment under consideration.
The dispute concerned its continuing validity. In 2020, PW had appointed her children as attorneys for health and welfare decisions, while withholding authority concerning life-sustaining treatment. She had not informed them about her earlier blood refusal. She also requested the removal of an incorrectly entered do-not-resuscitate notice from her medical records.
The court considered evidence that PW had subsequently expressed willingness to receive blood under certain circumstances, alongside statements supporting her earlier refusal. Mr Justice Poole concluded that her conduct and expressed wishes were clearly inconsistent with the advance decision remaining her fixed decision. The directive was invalid under section 25(2)(c), and transfusion was authorized following a best-interests assessment (Re PW, 2021, §§47–60).
The decision did not establish that an old directive automatically expires. Nor was the creation of a lasting power of attorney, without the relevant statutory conditions, sufficient on its own to invalidate the refusal. The judgment turned on the evidence concerning PW's particular conduct and intentions.
The September 2026 religious revision raises similar questions for patients who completed documents under the former policy. Such a directive may still accurately express the person's wishes, even if the denomination now permits some previously prohibited components. A change in religious guidance does not itself revoke an individual refusal. Its continuing legal effect depends on the patient and the applicable statutory requirements.
4.3 Emergency Intervention and Uncertain Patient Wishes
Emergency treatment may be required when a patient is unconscious, critically injured, or unable to communicate. Physicians may have limited time to establish treatment preferences, obtain documents, or determine whether an existing directive remains applicable.
The legality of intervention depends on the relevant circumstances. Where a valid and applicable refusal has been established, an emergency does not automatically remove its legal effect. Where capacity or the patient's authentic wishes remain genuinely uncertain, the law may permit essential treatment while appropriate inquiries or judicial proceedings take place.
Section 26(5) of the Mental Capacity Act 2005 recognizes a limited safeguard in this context. An apparent advance decision does not prevent life-sustaining treatment or measures reasonably believed necessary to prevent serious deterioration while a relevant question is being determined by the court. That provision does not authorize routine disregard of established refusals.
The Canadian case Malette v. Shulman (1990) illustrates the significance of prior medical instructions. Georgette Malette, an unconscious Jehovah’s Witness injured in a road accident, received blood despite carrying a card recording her refusal. The Ontario Court of Appeal upheld the finding of liability arising from the unauthorized transfusion, recognizing the importance of respecting the patient's previously expressed decision.
Malette and Pindo Mulla reached their conclusions through different legal systems. The former concerned Canadian private-law principles governing unauthorized medical intervention. The latter concerned a state's responsibilities under the European Convention on Human Rights. Both demonstrate that medical urgency must be considered alongside the patient's legally relevant wishes, rather than treated as an automatic source of authority to intervene.
5. Children, Religious Refusal, and the Right to Life
Children's medical decisions require a distinct legal analysis because individual rights, parental responsibilities, and state protection interact differently before adulthood. Parents ordinarily participate in decisions concerning their children's care, but religious convictions do not provide unlimited authority to refuse treatment that may be necessary to prevent serious harm.
The position of adolescents is more complex. Some minors understand their medical condition, the proposed intervention, and the consequences of refusing it. Their convictions may be independently formed and deeply important to their identity. National courts must determine the legal weight to give those views within the relevant child-protection framework.
The September 2026 revision may alter the treatment options some Jehovah’s Witness families consider religiously acceptable. It does not remove the legal responsibilities of healthcare professionals or courts when children's welfare is at stake.
5.1 The Best Interests of the Child
Article 3 of the Convention on the Rights of the Child requires the child's best interests to be a primary consideration in decisions affecting children. Article 6 protects life, survival, and development, while Article 24 recognizes the right to the highest attainable standard of health (Convention on the Rights of the Child, 1989).
Children also possess rights concerning participation and religious freedom. Article 12 requires appropriate weight to be given to their views according to age and maturity. Article 14 protects freedom of thought, conscience, and religion. Article 5 recognizes parental guidance consistent with the child's evolving capacities.
These protections prevent a child's legal position from being determined solely by parental religious affiliation. An infant cannot personally make the same informed decision as a mature adolescent. As children develop greater understanding, their own convictions acquire increasing significance in legal and medical assessments.
The Convention on the Rights of the Child establishes an international framework for these considerations, but it does not prescribe a universally applicable age at which refusal of life-saving treatment becomes legally conclusive. Its binding obligations apply to states parties, while domestic law supplies the procedures through which medical disputes are resolved.
The patient's circumstances remain central. The seriousness and probability of medical harm, the nature of proposed treatment, available alternatives, age, understanding, and potential consequences of unwanted intervention may all affect the assessment. Courts must evaluate welfare rather than assume that either parental wishes or the preservation of life always determines the result.
5.2 Mature Minors in English and Canadian Courts
In E & F (Minors: Blood Transfusion) [2021] EWCA Civ 1888, the Court of Appeal of England and Wales considered two Jehovah’s Witness adolescents who had refused blood transfusions. Both were regarded as competent to make the relevant medical decisions, and both had the support of their parents. Their clinical circumstances, however, were different.
E, aged 16 years and eight months, required urgent surgery for acute appendicitis. She consented to the operation but refused transfusion if serious bleeding occurred. F, aged 17 years and five months, had sustained a splenic injury and was receiving conservative treatment. His doctors were concerned about the possibility of subsequent hemorrhage, although no operation was planned.
The hospitals sought declarations permitting transfusion if necessary to prevent serious injury or death. The High Court authorized the proposed intervention in both cases, and the young people appealed. Neither ultimately required a transfusion.
The Court of Appeal dismissed the appeals, confirming that the High Court retained jurisdiction to authorize treatment in a minor's best interests despite a competent refusal. It nevertheless emphasized that the assessment must consider the likelihood and consequences of medical harm, the minor's maturity, personal convictions, and wider welfare (E & F, 2021).
A different outcome followed in Re J (Blood Transfusion: Older Child: Jehovah’s Witness) [2024] EWHC 1034 (Fam). J was 17 years and seven months old and required surgery to correct an obstruction affecting drainage from his left kidney. He consented to surgery but refused whole blood and its principal components if serious bleeding occurred.
Mr Justice Cobb examined the medical evidence, including the very low probability of severe hemorrhage, alongside J's maturity and understanding. J clearly explained his religious convictions and the psychological and spiritual consequences he anticipated if treatment were imposed against his wishes.
The court declined to authorize transfusion. It concluded that respecting J's refusal was consistent with his best interests in the particular circumstances. The judgment did not overrule E & F, which remained the controlling Court of Appeal authority. Rather, it demonstrated that the protective jurisdiction permits individualized outcomes and does not require authorization whenever a possible complication could be fatal.
Canadian jurisprudence provides a related comparison. In A.C. v. Manitoba (Director of Child and Family Services) 2009 SCC 30, the Supreme Court of Canada considered the case of a 14-year-old Jehovah’s Witness who opposed a transfusion. A court order had authorized treatment, and blood was administered. The Supreme Court upheld the relevant Manitoba legislation while recognizing the need to give meaningful consideration to the young person's maturity and independent understanding.
These decisions demonstrate that the legal position of a mature minor cannot be reduced to an absolute right to refuse or an automatic duty to intervene. The governing law differs between jurisdictions, and the weight given to autonomy depends on the individual welfare assessment.
6. Medical Practice After the September 2026 Revision
The September 2026 change has immediate implications for discussions between healthcare professionals and Jehovah’s Witness patients. Older institutional materials often describe members as categorically rejecting whole blood and its four principal components. That description no longer reflects the denomination's current official position, although individual members may continue to reject all of those products.
On November 5, 2026, the United Kingdom's National Blood Transfusion Committee drew attention to the revision and advised healthcare professionals to continue discussing and documenting each patient's wishes individually. The notice is professional institutional guidance rather than legislation. Its importance lies in recognizing that a patient's treatment preferences cannot reliably be inferred from religious identification alone (National Blood Transfusion Committee, 2026).
Clinical discussions may need to distinguish whole blood, red cells, white cells, platelets, plasma, smaller blood fractions, and procedures involving the patient's own blood. A member may accept one intervention while rejecting another. The relevant decision should be documented with sufficient precision to guide treatment, particularly where surgery or serious bleeding is anticipated.
Previously completed advance directives deserve careful attention. Some patients may have signed documents before the September announcement that exclude treatments now permitted under the revised religious guidance. Clinicians should establish whether those instructions remain valid and applicable under the governing law and whether the patient has personally revised them. Denominational permission is not a substitute for consent.
Blood-conservation measures remain relevant for patients who refuse particular products. Depending on the clinical circumstances, these may include identifying and treating anemia before surgery, minimizing procedural blood loss, using appropriate medication, and considering techniques that reduce transfusion requirements. The National Institute for Health and Care Excellence addresses several such approaches in its guideline Blood Transfusion (NG24).
These strategies are not interchangeable with transfusion in every medical situation. Their effectiveness depends on the patient's condition, the rate and severity of bleeding, the time available for treatment, and other clinical factors. A proposed alternative must be assessed for suitability rather than assumed to provide the same benefit as the refused intervention.
A patient's right to decline treatment also does not necessarily create an enforceable right to demand any preferred alternative. Healthcare professionals remain responsible for providing care consistent with clinical standards and the obligations of the relevant healthcare system. Respect for religious beliefs requires serious consideration of acceptable options, without obliging clinicians to provide procedures that are inappropriate or unavailable.
Questions concerning pressure and confidentiality also remain important. Relatives or religious representatives may assist patients in understanding available treatments, and hospital liaison committees can provide information about blood-conservation methods. Their participation must not displace the patient's independent decision. Where appropriate, confidential discussions can help clinicians establish whether the patient is expressing personal wishes freely.
The wider clinical consequences of the religious revision are not yet established. The official announcements demonstrate that members have additional permitted choices. They do not provide reliable figures showing how many patients have accepted those options, whether transfusion rates have changed, or whether mortality has been affected. Such conclusions require evidence about actual medical decisions and outcomes rather than assumptions based on the change in denominational policy.
Conclusion
Human rights law provides substantial protection for a competent adult's informed refusal of blood transfusion, including where the decision arises from religious conviction and may result in death. Under the European Convention on Human Rights, bodily autonomy is principally protected through Article 8, while Article 9 safeguards religious freedom and Article 2 establishes obligations concerning the protection of life. The application of these guarantees depends on the patient's circumstances and the legal safeguards governing medical intervention.
The protection is not identical for every patient. Advance refusals must satisfy the applicable requirements of validity and applicability. Genuine uncertainty about capacity or current wishes may justify emergency intervention under the relevant law. Children require a separate assessment involving their rights, maturity, welfare, and the state's protective responsibilities. The judicial decisions concerning adult patients and mature minors demonstrate why these distinctions cannot be replaced by a single rule.
The September 2026 revision of Jehovah’s Witnesses' blood policy has altered the religious options available to members without changing the fundamental requirement to establish individual medical consent. Isaac Valdez's death shortly before the announcement illustrates the potentially grave consequences of refusing treatment and the importance of understanding a patient's authentic wishes. The available evidence does not establish that his death caused the revision or that the new policy would necessarily have changed his decision or medical outcome.
The legal authority to accept or refuse treatment ultimately belongs to the patient where the law recognizes the person's capacity and informed choice. Religious teaching may influence that choice, but it cannot substitute for the individual's legally effective decision. Equally, the state's duty to protect life does not authorize the routine displacement of competent adult autonomy. The governing question is what the patient has validly decided, under which legal rules, and in what medical circumstances.
References
Association for the Advancement of Blood & Biotherapies (AABB) (2026a) ‘Jehovah’s Witnesses to Permit Autologous Blood Transfusion’ [online]. 24 March. Available at: https://www.aabb.org/news-resources/news/article/2026/03/24/jehovah-s-witnesses-to-permit-autologous-blood-transfusion (Accessed: 7 November 2026).
Association for the Advancement of Blood & Biotherapies (AABB) (2026b) ‘Jehovah’s Witnesses Allow Individual Decisions on Allogeneic Blood Transfusion and Donation’ [online]. 21 September. Available at: https://www.aabb.org/news-resources/news/article/2026/09/21/jehovah%27s-witnesses-allow-individual-decisions-on-allogeneic-blood-transfusion-and-donation (Accessed: 7 November 2026).
Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine (1997) Adopted 4 April 1997, entered into force 1 December 1999, European Treaty Series No. 164. Available at: https://www.coe.int/en/web/conventions/full-list?module=treaty-detail&treatynum=164 (Accessed: 7 November 2026).
Convention for the Protection of Human Rights and Fundamental Freedoms (European Convention on Human Rights) (1950) Signed 4 November 1950, entered into force 3 September 1953, European Treaty Series No. 5. Available at: https://www.echr.coe.int/documents/d/echr/convention_ENG (Accessed: 7 November 2026).
Convention on the Rights of the Child (1989) Adopted 20 November 1989, entered into force 2 September 1990, 1577 UNTS 3. Available at: https://treaties.un.org/pages/ViewDetails.aspx?chapter=4&mtdsg_no=IV-11&src=TREATY (Accessed: 7 November 2026).
Court of Appeal of England and Wales (2021) E & F (Minors: Blood Transfusion), judgment, 14 December, [2021] EWCA Civ 1888. Available at: https://www.judiciary.uk/wp-content/uploads/2022/07/E-v-Northern-Care-F-v-Somerset-judgment.pdf (Accessed: 7 November 2026).
Court of Protection of England and Wales (2021) Re PW (Jehovah’s Witness: Validity of Advance Decision), judgment, 22 September, [2021] EWCOP 52. Available at: https://www.judiciary.uk/judgments/pw-jehovahs-witness-validity-of-advance-decision/ (Accessed: 7 November 2026).
European Court of Human Rights (2010) Jehovah’s Witnesses of Moscow and Others v. Russia, judgment, 10 June, Application No. 302/02. Available at: https://hudoc.echr.coe.int/eng?i=001-99221 (Accessed: 7 November 2026).
European Court of Human Rights (2022) Taganrog LRO and Others v. Russia, judgment, 7 June, Application Nos. 32401/10 and 19 others. Available at: https://hudoc.echr.coe.int/eng?i=001-217535 (Accessed: 7 November 2026).
European Court of Human Rights (2024) Pindo Mulla v. Spain, Grand Chamber judgment, 17 September, Application No. 15541/20. Available at: https://hudoc.echr.coe.int/eng?i=001-236065 (Accessed: 7 November 2026).
High Court of England and Wales (2024) Re J (Blood Transfusion: Older Child: Jehovah’s Witness), judgment, 15 April, [2024] EWHC 1034 (Fam). Available at: https://www.judiciary.uk/wp-content/uploads/2024/05/University-Hospitals-Plymouth-NHS-Trust-v-J-and-others-Judgment.pdf (Accessed: 7 November 2026).
International Covenant on Civil and Political Rights (1966) Adopted 16 December 1966, entered into force 23 March 1976, 999 UNTS 171. Available at: https://treaties.un.org/pages/ViewDetails.aspx?chapter=4&mtdsg_no=IV-4&src=TREATY (Accessed: 7 November 2026).
Jehovah’s Witnesses (2026a) ‘2026 Governing Body Update #2’ [online]. 20 March. Available at: https://www.jw.org/en/news/region/global/2026-Governing-Body-Update-2/ (Accessed: 7 November 2026).
Jehovah’s Witnesses (2026b) ‘Jehovah’s Witnesses: Each Witness Now Decides Whether to Accept or Donate Main Blood Components’ [online]. 18 September. Available at: https://www.jw.org/en/global-communications/country/global-news/Jehovahs-Witnesses-Each-Witness-Now-Decides-Whether-to-Accept-or-Donate-Main-Blood-Components/ (Accessed: 7 November 2026).
Malette v. Shulman (1990) Ontario Court of Appeal, judgment, 30 March, 72 O.R. (2d) 417. Available at: https://cnps.ca/wp-content/uploads/2020/03/malette-v-shulman-et-al.-72-OR-2d-417.pdf (Accessed: 7 November 2026).
Maqbool, A. and Wyatt, C. (2026) ‘This man refused life-saving treatment because of his religion – days later the rules changed’, BBC News [online]. 7 November. Available at: https://www.bbc.co.uk/news/articles/cx5ynly549njo (Accessed: 7 November 2026).
Mental Capacity Act 2005 (United Kingdom) 2005 c. 9, Royal Assent 7 April 2005. Available at: https://www.legislation.gov.uk/ukpga/2005/9/part/1 (Accessed: 7 November 2026).
National Blood Transfusion Committee (2026) ‘Jehovah’s Witnesses: Each Witness Now Decides Whether to Accept or Donate Main Blood Components’ [online]. 5 November. Available at: https://www.nationalbloodtransfusion.co.uk/news/2026/jehovahs-witnesses-each-witness-now-decides-whether-accept-or-donate-main-blood (Accessed: 7 November 2026).
National Institute for Health and Care Excellence (2015, updated 2026) Blood transfusion. NICE Guideline NG24. London: National Institute for Health and Care Excellence. Available at: https://www.nice.org.uk/guidance/ng24/resources/blood-transfusion-pdf-1837331897029 (Accessed: 7 November 2026).
Ontario Court of Appeal (1990) Malette v. Shulman, judgment, 30 March, 72 O.R. (2d) 417. Available at: https://cnps.ca/wp-content/uploads/2020/03/malette-v-shulman-et-al.-72-OR-2d-417.pdf (Accessed: 7 November 2026).
Supreme Court of Canada (2009) A.C. v. Manitoba (Director of Child and Family Services), judgment, 26 June, 2009 SCC 30, [2009] 2 SCR 181. Available at: https://scc-csc.lexum.com/scc-csc/scc-csc/en/item/7795/index.do (Accessed: 7 November 2026).
UNESCO (2005) Universal Declaration on Bioethics and Human Rights. Adopted by the General Conference of UNESCO, Paris, 19 October. Available at: https://www.unesco.org/en/legal-affairs/universal-declaration-bioethics-and-human-rights (Accessed: 7 November 2026).
United Nations General Assembly (1948) Universal Declaration of Human Rights, Resolution 217 A (III), 10 December. Available at: https://www.un.org/en/about-us/universal-declaration-of-human-rights (Accessed: 7 November 2026).

